Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Convergent Technologies is a German diagnostics and medical technology company focused on integrated healthcare solutions and in vitro diagnostics. The company markets the Convergys product line, which includes point-of-care RT-PCR systems for COVID-19 and laboratory instruments for hematology, electrolyte analysis, blood gases, urinalysis, biochemistry, and related reagents. It also sells home-care monitoring products under the élégance brand, including blood glucose and blood pressure devices. The business appears to be commercial-stage rather than a therapeutics developer, with revenue generated from marketed diagnostic systems and consumables for laboratories, clinics, and decentralized testing settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Convergent Technologies.